Aktuelle wissenschaftliche Publikationen aus der Klinik

  • Fares A, Borrmann D. Neurochemical Aspects of Alzheimer's Disease and Movement Disturbances: A Theory of β-Amyloid and τ-Protein. Am J Alzheimers Dis Other   Demen. 2018 Jul 25:1533317518790631.
  • Fares A. Pharmacological and non-pharmacological means to prevent fractures among elderly. Int J Prev Med 2018;9:78.
  • Fares A. Seasonality of hepatitis: a review update. J Family Med Prim Care   2015 Jan-Mar;4(1):96-100.
  • Fares A. Summer appendicitis. Ann Med Health Sci Res. 2014 Jan;4(1):18-21.
  • Fares, A. Global patterns of seasonal variation of gastrointestinal diseases. J Postgrad Med. 2013 Jul-Sep;59(3):203-7.
  • Fares, A. Winter hypertension: Potential mechanism. International Journal of Health Sciences, Qassim University, Vol. 7, No. 2 (June 2013/ Sha’ban 1434H).
  • Fares A.  Factors  influencing the  seasonal  patterns  of  infectious diseases. Int  J  Prev Med.2013;4:128-32.
  • Fares A. Winter cardiovascular diseases phenomenon. North Am J Med Sci 2013;5:266-79.
  • Fares A. Hypothesis: Are beta-blockers safe for patients with multiple sclerosis? Int J Nutr Pharmacol Neurol Dis 2013;3:73-6.
  • Fares, A. Seasonality of viral hepatitis. J Acad Med Sci 2012;2:110-4.
  • Fares, A. Use of beta-blockers and risk of dementia in the elderly patients. J Neuropsychiatry Clin Neurosci. 2012 Sep 1;24(4):E20-1.
  • Fares, A. Racial differences in susceptibility to infection by Mycobacterium tuberculosis. Ann Trop Med Public Health 2012; 5:307-12.
  • Fares A, Seasonality of tuberculosis. J Glob Infect Dis. 2011 Jan;3(1):46-55.
  • Fares, A. Night-time exogenous melatonin administration may be a beneficial treatment for sleeping disorders in beta blocker patients. J Cardiovasc Dis Res 2011;2:153-5.
  • Fares A. Hypothesis: Melatonin and its possible role in mediating the seasonal variability of tuberculosis. Chron Young Sci 2011;2:227-8.
  • Fares, Auda, Borrmann, Dieter, Ivester, Julius R.. Are statins beneficial for the treatment of SARS-CoV-2 infection?. Journal of Infection Prevention: 1757177420982049, 2021.
  • Fares A., Toprak R., Borrmann D., Ivester JR.: The Use of α1‑Adrenergic Receptor Antagonists in the Prevention of Adverse Outcomes of COVID‑19 Infection in Obese Patients. Advances in Human Biology, 2022; Link zum Artikel
  • Fares A, Taib A, Toprak R (2022) Seasonality of Acute Cholecystitis: A Review of Global Patterns. Int J Surg Res Pract 9:146., Link zum Artikel